Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q3 2024 Interim Report on 22 October 2024 at 7:00 CET.

A conference call will be hosted on the same date at 9:00 CET / 7:00 GMT / 3:00am EST. The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English. Slides used in the presentation will be made available on the company website.

The conference call webcast can be accessed through following link:

Embla Medical Q3 2024 webcast

To actively participate in the Q&A session during the call please use following link for dial in options:

Registration form for Conference Call Q&A